Global and China Human Insulin Industry Market Research Report (2017-2028)

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Human Insulin industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Sanofi (France)

    • Ypsomed AG (Switzerland)

    • Becton

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Short Acting Human Insulin

    • Intermediate Acting Human Insulin

    • Premixed Human Insulin

    Application:

    • Insulin Dependent Diabetes Mellitus

    • Non-Insulin Dependent Diabetes Mellitus

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Human Insulin Industry Overview

      • 1.1.1 Human Insulin Market Scope and Market Segments

      • 1.1.2 Human Insulin Industry Characteristics

      • 1.1.3 Global and China Human Insulin Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Human Insulin Production Value and Growth Rate (2017-2028)

    • 1.2 Global Human Insulin Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Short Acting Human Insulin

      • 1.2.2 Intermediate Acting Human Insulin

      • 1.2.3 Premixed Human Insulin

    • 1.3 Global Human Insulin Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Insulin Dependent Diabetes Mellitus

      • 1.3.2 Non-Insulin Dependent Diabetes Mellitus

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Human Insulin Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Human Insulin Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Human Insulin Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Human Insulin Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Human Insulin Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Human Insulin Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Human Insulin Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Human Insulin Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Human Insulin Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Human Insulin Industry Porter's Five Forces Model Analysis

      • 2.2.3 Human Insulin Industry PEST Analysis

    • 2.3 Human Insulin Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Human Insulin Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Human Insulin Industry

    Chapter 3 Global and China Human Insulin Market, by Manufacturer

    • 3.1 Global and China Human Insulin Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Human Insulin Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Human Insulin Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Human Insulin Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Human Insulin Market Top 3 Players

    Chapter 4 Global and China Human Insulin Market, by Type (2017-2028)

    • 4.1 Human Insulin Market Trend, by Type

    • 4.2 Global Human Insulin Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Human Insulin Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Human Insulin Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Human Insulin Price Trend, by Type (2017-2028)

    • 4.3 China Human Insulin Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Human Insulin Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Human Insulin Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Human Insulin Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Human Insulin Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Human Insulin Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Human Insulin Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Human Insulin Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Human Insulin Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Human Insulin Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Human Insulin Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Human Insulin Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Human Insulin Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Human Insulin Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Human Insulin Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Human Insulin Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Human Insulin Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Human Insulin Market Analysis

    • 7.1 North America Human Insulin Market, by Type

    • 7.2 North America Human Insulin Market, by Application

    • 7.3 North America Human Insulin Market Analysis and Forecast, by Country

      • 7.3.1 United States Human Insulin Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Human Insulin Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Human Insulin Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Human Insulin Market Analysis

    • 8.1 Europe Human Insulin Market, by Type

    • 8.2 Europe Human Insulin Market, by Application

    • 8.3 Europe Human Insulin Market Analysis and Forecast, by Country

      • 8.3.1 Germany Human Insulin Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Human Insulin Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Human Insulin Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Human Insulin Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Human Insulin Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Human Insulin Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Human Insulin Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Human Insulin Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Human Insulin Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Human Insulin Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Human Insulin Market Analysis

    • 9.1 APAC Human Insulin Market, by Type

    • 9.2 APAC Human Insulin Market, by Application

    • 9.3 APAC Human Insulin Market Analysis and Forecast, by Country

      • 9.3.1 China Human Insulin Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Human Insulin Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Human Insulin Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Human Insulin Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Human Insulin Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Human Insulin Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Human Insulin Market Analysis

    • 10.1 Latin America, Middle East and Africa Human Insulin Market, by Type

    • 10.2 Latin America, Middle East and Africa Human Insulin Market, by Application

    • 10.3 Latin America, Middle East and Africa Human Insulin Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Human Insulin Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Human Insulin Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Human Insulin Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Human Insulin Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Human Insulin Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Human Insulin Company Profiles

      • 11.1 Sanofi (France)

        • 11.1.1 Sanofi (France) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Sanofi (France) Human Insulin Product Profiles, Application and Specification

        • 11.1.3 Sanofi (France) Human Insulin Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Ypsomed AG (Switzerland)

        • 11.2.1 Ypsomed AG (Switzerland) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Ypsomed AG (Switzerland) Human Insulin Product Profiles, Application and Specification

        • 11.2.3 Ypsomed AG (Switzerland) Human Insulin Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Becton

        • 11.3.1 Becton Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Becton Human Insulin Product Profiles, Application and Specification

        • 11.3.3 Becton Human Insulin Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Human Insulin Industry Investment Prospect and Risk Assessment

    • 12.1 Human Insulin Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Human Insulin Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Human Insulin Sales Volume and Growth Rate (2017-2028)

    • Figure China Human Insulin Sales Volume and Growth Rate (2017-2028)

    • Figure Global Human Insulin Production Value and Growth Rate (2017-2028)

    • Figure China Human Insulin Production Value and Growth Rate (2017-2028)

    • Figure Global Human Insulin Market Size and Growth Rate of Short Acting Human Insulin (2017-2028)

    • Figure Global Human Insulin Market Size and Growth Rate of Intermediate Acting Human Insulin (2017-2028)

    • Figure Global Human Insulin Market Size and Growth Rate of Premixed Human Insulin (2017-2028)

    • Figure Global Human Insulin Market Size and Growth Rate of Insulin Dependent Diabetes Mellitus (2017-2028)

    • Figure Global Human Insulin Market Size and Growth Rate of Non-Insulin Dependent Diabetes Mellitus (2017-2028)

    • Figure North America Human Insulin Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Human Insulin Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Human Insulin Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Human Insulin Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Human Insulin Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Human Insulin Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Human Insulin Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Human Insulin Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Human Insulin Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Human Insulin Market Share, by Manufacturer in 2021

    • Figure Global and China Human Insulin Market Share, by Manufacturer in 2022

    • Table Global Human Insulin Sales Volume, by Type (2017-2028)

    • Table Global Human Insulin Sales Volume Share, by Type (2017-2028)

    • Figure Global Human Insulin Sales Volume Share, by Type (2017-2028)

    • Table Global Human Insulin Sales Value, by Type (2017-2028)

    • Table Global Human Insulin Sales Value Share, by Type (2017-2028)

    • Figure Global Human Insulin Price Trend, by Type (2017-2028)

    • Table China Human Insulin Sales Volume, by Type (2017-2028)

    • Table China Human Insulin Sales Volume Share, by Type (2017-2028)

    • Figure China Human Insulin Sales Volume Share, by Type (2017-2028)

    • Table China Human Insulin Sales Value, by Type (2017-2028)

    • Table China Human Insulin Sales Value Share, by Type (2017-2028)

    • Figure China Human Insulin Price Trend, by Type (2017-2028)

    • Table Global Human Insulin Sales Volume, by Application (2017-2028)

    • Table Global Human Insulin Sales Volume Share, by Application (2017-2028)

    • Figure Global Human Insulin Sales Volume Share, by Application (2017-2028)

    • Table Global Human Insulin Sales Value, by Application (2017-2028)

    • Table Global Human Insulin Sales Value Share, by Application (2017-2028)

    • Figure Global Human Insulin Sales Value Share, by Application (2017-2028)

    • Table China Human Insulin Sales Volume, by Application (2017-2028)

    • Table China Human Insulin Sales Volume Share, by Application (2017-2028)

    • Figure China Human Insulin Sales Volume Share, by Application (2017-2028)

    • Table China Human Insulin Sales Value, by Application (2017-2028)

    • Table China Human Insulin Sales Value Share, by Application (2017-2028)

    • Figure China Human Insulin Sales Value Share, by Application (2017-2028)

    • Figure China Human Insulin Production, Import, Consumption and Export (2017-2022)

    • Figure North America Human Insulin Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Human Insulin Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Human Insulin Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Human Insulin Production, Import, Consumption and Export (2017-2022)

    • Table North America Human Insulin Sales Volume, by Type (2017-2028)

    • Table North America Human Insulin Sales Volume Share, by Type (2017-2028)

    • Figure North America Human Insulin Sales Volume Share, by Type (2017-2028)

    • Table North America Human Insulin Sales Volume, by Application (2017-2028)

    • Table North America Human Insulin Sales Volume Share, by Application (2017-2028)

    • Figure North America Human Insulin Sales Volume Share, by Application (2017-2028)

    • Figure United States Human Insulin Sales Volume and Growth Rate (2017-2028)

    • Figure United States Human Insulin Sales Value and Growth Rate (2017-2028)

    • Figure Canada Human Insulin Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Human Insulin Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Human Insulin Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Human Insulin Sales Value and Growth Rate (2017-2028)

    • Table Europe Human Insulin Sales Volume, by Type (2017-2028)

    • Table Europe Human Insulin Sales Volume Share, by Type (2017-2028)

    • Figure Europe Human Insulin Sales Volume Share, by Type (2017-2028)

    • Table Europe Human Insulin Sales Volume, by Application (2017-2028)

    • Table Europe Human Insulin Sales Volume Share, by Application (2017-2028)

    • Figure Europe Human Insulin Sales Volume Share, by Application (2017-2028)

    • Figure Germany Human Insulin Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Human Insulin Sales Value and Growth Rate (2017-2028)

    • Figure UK Human Insulin Sales Volume and Growth Rate (2017-2028)

    • Figure UK Human Insulin Sales Value and Growth Rate (2017-2028)

    • Figure France Human Insulin Sales Volume and Growth Rate (2017-2028)

    • Figure France Human Insulin Sales Value and Growth Rate (2017-2028)

    • Figure Italy Human Insulin Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Human Insulin Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Human Insulin Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Human Insulin Sales Value and Growth Rate (2017-2028)

    • Figure Spain Human Insulin Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Human Insulin Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Human Insulin Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Human Insulin Sales Value and Growth Rate (2017-2028)

    • Figure Poland Human Insulin Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Human Insulin Sales Value and Growth Rate (2017-2028)

    • Figure Russia Human Insulin Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Human Insulin Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Human Insulin Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Human Insulin Sales Value and Growth Rate (2017-2028)

    • Table APAC Human Insulin Sales Volume, by Type (2017-2028)

    • Table APAC Human Insulin Sales Volume Share, by Type (2017-2028)

    • Figure APAC Human Insulin Sales Volume Share, by Type (2017-2028)

    • Table APAC Human Insulin Sales Volume, by Application (2017-2028)

    • Table APAC Human Insulin Sales Volume Share, by Application (2017-2028)

    • Figure APAC Human Insulin Sales Volume Share, by Application (2017-2028)

    • Figure China Human Insulin Sales Volume and Growth Rate (2017-2028)

    • Figure China Human Insulin Sales Value and Growth Rate (2017-2028)

    • Figure Japan Human Insulin Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Human Insulin Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Human Insulin Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Human Insulin Sales Value and Growth Rate (2017-2028)

    • Figure India Human Insulin Sales Volume and Growth Rate (2017-2028)

    • Figure India Human Insulin Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Human Insulin Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Human Insulin Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Human Insulin Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Human Insulin Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Human Insulin Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Human Insulin Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Human Insulin Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Human Insulin Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Human Insulin Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Human Insulin Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Human Insulin Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Human Insulin Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Human Insulin Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Human Insulin Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Human Insulin Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Human Insulin Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Human Insulin Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Human Insulin Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Human Insulin Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Human Insulin Sales Value and Growth Rate (2017-2028)

    • Table Sanofi (France) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sanofi (France) Product Profiles, Application and Specification

    • Table Sanofi (France) Human Insulin Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ypsomed AG (Switzerland) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ypsomed AG (Switzerland) Product Profiles, Application and Specification

    • Table Ypsomed AG (Switzerland) Human Insulin Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Becton Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Becton Product Profiles, Application and Specification

    • Table Becton Human Insulin Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.